680 hasil
Menampilkan 1–20 · 0,49 detik · RSS
Expert Review of Vaccines
Scopus
ISSN 1744-8395 · Taylor & Francis Group · 680 artikel di indeks
-
Artikel Jurnal
Vaccines preventing neonatal sepsis: focus on Group B Streptococcus, Klebsiella pneumoniae and Escherichia coli to combat rising antimicrobial resistance
Introduction Neonatal sepsis, a systemic infection occurring in infants within their first 28 days of life, is a leading cause of mortality globally. The burden is especially severe in low- and middle-income countries (LMICs), where incidence and mortality rates are higher than in high-resource…
-
Artikel Jurnal
A self-controlled case series study on the safety of a live attenuated herpes zoster vaccine in China
Background Herpes zoster (HZ), caused by varicella-zoster virus, primarily affects the elderly. In May 2023, the first domestically produced live attenuated zoster vaccine was approved for use in adults aged 40 years or older in China.Research design and methods We conducted a self-controlled case…
-
Artikel Jurnal
Fc-mediated immune effector functions elicited by recombinant and live-attenuated herpes zoster vaccines
Background The role of Fc-mediated immune responses in protecting against herpes zoster remains poorly understood. This study aimed to evaluate the Fc-mediated immune responses of anti-VZV glycoprotein E antibodies induced by two licensed varicella-zoster virus vaccines.Research design and methods…
-
Artikel Jurnal
The health and economic burden of invasive pneumococcal diseases attributable to PCV21 versus PCV20 serotypes among adults aged ≥18 in Germany
Background Significant residual burden of invasive pneumococcal disease (IPD) is attributable to Streptococcus pneumoniae serotypes not included in any available vaccines in Germany. This study quantified the burden of invasive pneumococcal disease attributable to PCV21 and PCV20 serotypes among…
-
Artikel Jurnal
Influenza vaccination willingness and influencing factors among older adults in Chongqing China: a cross-sectional study based on the WHO’s behavioral and social drivers of vaccination framework
Background In the context of China’s aging population and low influenza vaccine coverage, this study applied the Behavioral and Social Drivers (BeSD) framework to investigate the willingness and determinants of influenza vaccination among adults aged ≥60 years in Chongqing.Research design and…
-
Artikel Jurnal
Preventing COVID-19 in at-risk populations: moving toward next-generation mRNA-1283 COVID-19 vaccine to address current challenges
Introduction Next-generation COVID-19 vaccines hold promise to reduce severe outcomes in populations most at risk. While the original mRNA COVID-19 vaccine, mRNA-1273, targets the full-length SARS-CoV-2 spike protein, mRNA-1283 is a novel next-generation mRNA COVID-19 vaccine that specifically…
-
Artikel Jurnal
Vaccine hesitancy among 0–6-year-olds’ guardians in Chongqing: a cross-sectional survey revealing how immunization program managers’ robust comprehensive capacity for adverse events following immunization (AEFI) management mitigates hesitancy
Background Vaccine hesitancy hinders optimal immunization coverage with fear of adverse events following immunization (AEFI) as a key driver. This study examines how robust district-level AEFI management capacity alleviates vaccine hesitancy among guardians of 0–6-year-olds in Chongqing…
-
Artikel Jurnal
Adjuvanted-RSVPreF3 vaccine uptake and effectiveness in individuals with COPD: a nationwide Danish cohort study
Background Individuals with chronic obstructive pulmonary disease (COPD) face increased risk of severe respiratory syncytial virus (RSV)-related outcomes. We assessed the uptake of adjuvanted-RSVPreF3 and its effectiveness against RSV hospitalization in such individuals.Research design and methods…
-
Artikel Jurnal
Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using a COVID-19 vaccine in Costa Rica
Background Using adapted COVID-19 vaccines targeting current variants in circulation is necessary for addressing the dynamic evolution of the SARS-CoV-2 virus and protecting against emerging variants.Research design and methods Using a previously published, combined Markov-decision tree model…
-
Artikel Jurnal
Adherence and efficacy of the 0 − 7 − 21-day versus the 0 − 1 − 6-month hepatitis B vaccination schedules among people who use drugs: a two-year randomized controlled trial
Background To compare the adherence and efficacy between the 0 − 7 − 21-day and the 0 − 1 − 6-month hepatitis B virus (HBV) vaccination schedules among people who use drugs (PWUD) in China.Research design and methods A randomized controlled trial was conducted in 1261 HBV-susceptible PWUD from…
-
Artikel Jurnal
Vaccines against chronic Trypanosoma cruzi infection: progress, challenges and future directions
Introduction Chronic infections with Trypanosoma cruzi can lead to Chagas disease, with cardiac and/or digestive debilitating manifestations. There has been a renewed interest in vaccine development against this neglected tropical disease in the past decades.Areas covered Vaccines ranging from live…
-
Artikel Jurnal
Cost-effectiveness of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus (RSV) among patients with chronic obstructive pulmonary disease in Italy
Background Chronic obstructive pulmonary disease (COPD) increases the risk of severe respiratory syncytial virus (RSV)-related disease. This analysis evaluated the potential public health impact and cost-effectiveness of RSV vaccination with a single dose of adjuvanted RSVPreF3 vaccine over five…
-
Artikel Jurnal
A human Lyme disease vaccine: two steps forward on the path to prevention
Introduction Lyme disease is caused by the tick-borne spirochete pathogen Borrelia burgdorferi sensu lato (s.l.). Outer surface protein A (OspA) is expressed by B. burgdorferi s.l. while in the tick and antibodies against OspA introduced into the tick with the bloodmeal can prevent transmission…
-
Artikel Jurnal
Cost-effectiveness of the adjuvanted respiratory syncytial virus prefusion F protein (RSVPreF3) vaccine in Japanese adults aged 50–59 years at increased risk of severe RSV disease and those aged ≥60 years
Background Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality in adults aged 50–59 years at increased risk of severe RSV disease due to specific underlying conditions (i.e. ’50–59 years at-increased-risk [AIR] population’), and in older adults aged ≥60 years (i.e. ‘≥60…
-
Artikel Jurnal
Differing influenza vaccine uptake and recommendation behavior among healthcare workers in primary health centers, secondary and tertiary hospitals, and schools in a metropolis of southern China
Background Healthcare workers (HCWs) play a key role in recommending influenza vaccination. Few studies have examined HCWs’ influenza vaccination and recommendation behavior in China.Research design and methods A cross-sectional survey was conducted among HCWs in primary health centers, secondary…
-
Artikel Jurnal
Association of mRNA SARS-CoV-2 vaccination with fatigue and functional recovery in patients with post-acute sequelae of COVID-19 (PASC)
Background Patients with post-acute sequelae of SARS-CoV-2 (PASC) fear SARS-CoV-2 vaccine-linked symptom aggravation. Data on objective functional outcomes are limited.Methods We performed a retrospective analysis of an observational cohort at a post-COVID outpatient clinic at Hannover Medical…
-
Artikel Jurnal
Global vaccine readiness: equity-by-design in pandemic preparedness and response
Introduction COVID-19 showed that rapid vaccine development and roll-out, while lifesaving, can still yield large, avoidable harms when equity is not considered from the outset. Disparities in vaccine timing and coverage, especially in low-resource settings, amplified health and economic burdens…
-
Artikel Jurnal
Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission model
Background This study assessed the public health impact of adult pneumococcal vaccination strategies in Japan, comparing 20-valent (PCV20) and 21-valent (V116) pneumococcal conjugate vaccines with the current 23-valent polysaccharide vaccine (PPSV23).Methods An age- and serotype-specific dynamic…